The Case for Functional Oculomics

Rehan Ahmed, MDFor the past several years, oculomics has been dominated by a single idea: the retina as a window into systemic disease.

 

We’ve built increasingly sophisticated ways to image the fundus, extracting structural biomarkers to estimate risk for conditions like diabetes, cardiovascular disease and even Alzheimer’s. That work matters. Structural signals are powerful, reproducible and clinically intuitive.

 

But they are only part of the story.

 

In our focus on imaging, we’ve quietly adopted a narrow mental model of the eye — treating it as a static camera rather than what it truly is: a high-speed motor organ, deeply integrated with cognition and tightly coupled to the autonomic nervous system.

 

We’ve spent years analyzing the hardware. We’ve paid far less attention to the software.

How Does the Eye Behave?

The next meaningful advance in eye-based health diagnostics is unlikely to come from imaging alone. It will come from understanding how the eye behaves.

 

That shift became clearer this week with the acquisition of iFocus Health by HarmonEyes. The value wasn’t in sharper images or better optics. It was in kinetics. By measuring saccadic velocity and fixation stability using an ordinary webcam, iFocus demonstrated that eye movements can serve as objective markers of ADHD treatment response. Executive function, in other words, leaves a measurable signature in ocular motor control.

 

That insight is important — but ADHD is just the beginning.

Functional Oculomics

What’s emerging now is functional oculomics: the systematic study of eye behavior as a proxy for neurologic, cognitive and autonomic function.

 

Consider the pupil. Historically, we’ve treated it as a simple light-regulated aperture. In reality, it’s one of the most sensitive, continuously accessible indicators of internal state.

 

Cognitive load produces subtle, involuntary pupil dilation. Emotional arousal—fear, excitement, stress—can override the classic light reflex through sympathetic activation. Long before we had algorithms, Renaissance women used belladonna to dilate their pupils as a signal of attraction. They intuitively understood what we are now quantifying: pupil size reflects desire, attention and emotional state.

 

And the pupil is only one signal.

 

Parkinson’s disease manifests as abnormalities in microsaccades, pursuit and blink dynamics years before a classic resting tremor appears. Fatigue shows up in blink patterns and sustained eyelid closure well before performance deteriorates. Anxiety, depression, concussion, cognitive decline and autonomic dysfunction all leave fingerprints in eye movements that are measurable with today’s computer vision tools.

 

Crucially, many of these signals can be captured without specialized hardware. A standard camera—even a consumer webcam—is often sufficient. That’s what makes functional oculomics so disruptive. It shifts eye-based diagnostics from specialized clinics to scalable, software-driven platforms.

 

This doesn’t replace retinal imaging. It complements it.

Continuous Observation is Key

The retina gives us anatomy. The anterior segment gives us behavior. Anatomy tells us what is. Behavior tells us what’s happening.

 

Yet much of this data is still being ignored. We look through the eye without truly watching it. We capture images but miss motion. We quantify structure but overlook function.

 

As AI matures, the most valuable insights will come not from a single snapshot, but from continuous, dynamic observation. The eye is uniquely suited for that role — visible, information-dense and directly linked to the nervous system.

 

The future of oculomics isn’t just about seeing more.

 

It’s about paying attention to what the eye is already telling us.

Author

  • Rehan Ahmed, MD

    Rehan Ahmed, MD is a board-certified ophthalmologist passionate about improving eye care. He has extensive experience in the wide spectrum of eye care – from direct medical and surgical patient care to managing medical optometry and ophthalmology practice environments to innovating in drug and device development.

    Dr. Ahmed is a practicing ophthalmologist and Chief Medical Officer at Blink, a start-up in remote ocular health care. He also works with pharmaceutical companies in the clinical design, both early and late stage studies in multiple eye indications. Dr. Ahmed received his MD degree from Vanderbilt University School of Medicine. He completed his internship at the University of Texas, residency in ophthalmology at Baylor College of Medicine, and MBA from MIT Sloan School of Management.



    View all posts


Leave a Reply

Your email address will not be published. Required fields are marked *